Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1333 of 5804
-
Brain hack zaps phobias while you relax – no spiders needed!
Symptom relief Recruiting nowThis application investigates the efficacy of a novel method of neuro-reinforcement based on decoded fMRI activity to reduce fear responses in individuals with phobias (e.g., spiders, snakes). This method works unconsciously in the brain, without the need for participants to endu…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
New device aims to unclog stents in leg veins
Disease control Recruiting nowThe purpose of this research is to collect information about how the RevCore Thrombectomy Catheter works to treat stent blockages.
Sponsor: Inari Medical • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New 24-Valent pneumonia vaccine shows promise in kids trial
⭐️ VACCINE ⭐️ CompletedA Phase Ia clinical trial of 24-valent pneumococcal conjugate vaccine (PCV24) developed by Sinovac Life Science Co., Ltd will be conducted in children aged 2-17 years. The objective of the study is to evaluate the safety and immunogenicity of Sinovac PCV24. The trial is a randomi…
Phase: PHASE1 • Sponsor: Sinovac Life Sciences Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:00 UTC
-
New study aims to find best method for removing Pre-Cancerous colon polyps
Disease control ENROLLING_BY_INVITATIONThe study will compare the use of cold snare piecemeal resection (CSPR) vs cold endoscopic mucosal resection (Cold EMR). The study will include two cohorts: one cohort for conventional adenomas 10-19mm in size and one cohort for serrated lesions 10mm or larger.
Phase: NA • Sponsor: Indiana University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Could a simple cream shield cancer patients from radiation burns?
Prevention Recruiting nowThe incidence of radiation-induced skin injury is high, and effective preventive measures are currently lacking. This study evaluates the role of the skin protective agent Pinoxin in preventing skin injury. Patients are randomly assigned into two prospective groups: treatment gro…
Phase: PHASE2 • Sponsor: Fudan University • Aim: Prevention
Last updated Jun 27, 2026 12:23 UTC
-
New study tracks best approaches for returning abdominal sarcoma
Disease control Recruiting nowThe aim of the study is to collect prospective data on the treatment outcomes in patients with first localized, resectable recurrent retroperitoneal well-differentiated and/or dedifferentiated liposarcoma undergoing curative intent treatment. Patients enrolled in this study will …
Sponsor: Australia and New Zealand Sarcoma Association • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New pill targets Hard-to-Treat lymphoma in first human trial
Disease control Recruiting nowThis clinical trial is studying the safety and potential anti-tumor activity of an investigational drug called ARV-393 in patients diagnosed with advanced Relapsed/Refractory non-Hodgkin's lymphoma (R/R NHL) to determine if ARV-393 may be a possible treatment option. ARV-393 is …
Phase: PHASE1 • Sponsor: Arvinas Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New pill aims to slow lung scarring in IPF patients
Disease control CompletedThis study is open to adults 40 years or older with idiopathic pulmonary fibrosis (IPF). People can join the study if they are not on any treatment for IPF are on stable treatment for at least 3 months before starting the study. The purpose of this study is to find out whether a …
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Can a single drug stop dengue in its tracks?
Disease control CompletedThis randomized, placebo controlled single center study examines the extent to which 600 mg/m2/day of orally administered ISLA101 (fenretinide), given prophylactically or therapeutically, may reduce or eliminate signs and symptoms of dengue virus (DENV) infection over 29 days fol…
Phase: PHASE2 • Sponsor: Island Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Engineered immune cells take on deadliest brain cancer
Disease control Recruiting nowThis is a phase I, open-Label, single/multiple dose, dose-escalation study to evaluate the safety, tolerability and antitumor activity of anti-B7-H3 CAR-T cell injection (TX103) in subjects with recurrent or progressive Grade 4 Glioma.The study also plan to explore the Maximum To…
Phase: PHASE1 • Sponsor: Tcelltech Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New psoriasis pill tested for Long-Term safety in thousands of patients
Disease control OngoingThe main aim of this study is to check the side effects of TAK-279 and how well it is tolerated in participants with moderate-to-severe plaque psoriasis. All participants will be assigned to study treatments of TAK-279 and will be treated with TAK-279 if the participants meet th…
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Cool roofs trial aims to beat the heat and boost health
Disease control Recruiting nowAmbient air temperatures in Asian, Latin American, African, and Pacific climate hotspots have broken record highs in 2024, driven by man-made climate change. Solutions are needed to reduce heat exposure in communities. Sunlight-reflecting cool roof coatings passively reduce indoo…
Phase: NA • Sponsor: Aditi Bunker • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New drug aims to ease lung pressure in heart failure patients
Disease control OngoingTX000045-003 is a double-blind, randomized, parallel group, placebo-controlled, proof- of-concept (POC) study, evaluating 2 dose regimens of TX000045 over the course of a 24-week treatment period (the APEX study).
Phase: PHASE2 • Sponsor: Tectonic Therapeutic • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Experimental vaccine fights sarcoma with Patient's own immune cells
Disease control Recruiting nowThe primary objective of this trial is to evaluate the safety and tolerability of the tumor neoantigen vaccine (SarcVac) in combination with a PD-1 antibody, with or without tumor-specific lymphocytes, in patients with advanced bone and soft tissue sarcoma who have failed first-l…
Phase: PHASE1 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New antibody takes on Hard-to-Treat myeloma
Disease control OngoingA Phase 1b, Multicenter, Open-Label, Study to Investigate the Safety and Efficacy of CLN-619 (anti-MICA/MICB Antibody) in Patients with Relapsed and Refractory Multiple Myeloma
Phase: PHASE1 • Sponsor: Cullinan Therapeutics Inc. • Aim: Disease control
Last updated Jun 26, 2026 17:50 UTC
-
Could early use of a 'Smart' stimulator tame CRPS pain?
Symptom relief Recruiting nowThe primary purpose of this study is to determine the differences in response to treatment of complex regional pain syndrome with a closed-loop spinal cord stimulator if applied in the early phases (acute or subacute) versus the chronic phase.
Phase: NA • Sponsor: Scripps Health • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
New Once-Daily pill could ease Post-Surgery pain
Symptom relief CompletedThe purpose of this study is to evaluate the efficacy and safety of Cebranopadol for acute pain after a Abdominoplasty.
Phase: PHASE3 • Sponsor: Tris Pharma, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Metal mesh implanted in eye could halt keratoconus
Disease control Recruiting nowThis Study is a First In Human clinical investigation addressed to evaluate the safety and efficacy of a novel intra-corneal nitinol device (Investigational Medical Device: GROSSO® implant) for the treatment of advanced keratoconus disease of the eye.
Phase: NA • Sponsor: Recornea Srl • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Cash for quitting: Family-Based incentives aim to help alaska natives kick the habit
Disease control Recruiting nowThe current study will conduct an RCT to evaluate the effectiveness of a family-based incentive intervention with Alaska Native/American Indian families. The experimental arm will be compared to a control arm on biochemically-confirmed smoking abstinence at 6- and 12-months post-…
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New inhaled drug shows promise for Long-Term control of rare lung disease
Disease control OngoingThis open-label extension study will evaluate the long-term safety, tolerability and efficacy of orally inhaled seralutinib in subjects who have completed a previous seralutinib study
Phase: PHASE3 • Sponsor: GB002, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC